Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001983155 | SCV002241521 | uncertain significance | not provided | 2021-11-23 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with ENPP1-related conditions. This variant is present in population databases (rs771405037, gnomAD 0.007%). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 124 of the ENPP1 protein (p.Ala124Thr). |
Ambry Genetics | RCV002564408 | SCV003643755 | uncertain significance | Inborn genetic diseases | 2022-08-29 | criteria provided, single submitter | clinical testing | The c.370G>A (p.A124T) alteration is located in exon 3 (coding exon 3) of the ENPP1 gene. This alteration results from a G to A substitution at nucleotide position 370, causing the alanine (A) at amino acid position 124 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005032029 | SCV005667180 | uncertain significance | Arterial calcification, generalized, of infancy, 1; Type 2 diabetes mellitus; Hypophosphatemic rickets, autosomal recessive, 2; Hypopigmentation-punctate palmoplantar keratoderma syndrome; Inherited obesity | 2024-02-03 | criteria provided, single submitter | clinical testing |